Showing results (221-230 of 270) with videos related to

Sort By:
Pageof 27
Breast Cancer Research and Treatment|February 3, 2007
Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)Jennifer M Specht, Stephen L Tam, Brenda F Kurland, et al.
Acta Anaesthesiologica Scandinavica|July 1, 1996
Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tractC D Spies, A Nordmann, G Brummer, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Validation of heat shock protein 70 as a tumor-specific biomarker for monitoring the outcome of radiation therapy in tumor mouse modelsChristine Bayer, Michael E Liebhardt, Thomas E Schmid, et al.
ESMO Open|April 11, 2025
Afatinib in patients with solid tumors with neuregulin 1 (NRG1) fusions: a case series from the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyJ Rodon, M Rothe, P K Mangat, et al.
Research Square|February 5, 2024
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trialsMark Muzi, Lanell M Peterson, Jennifer M Specht, et al.
EJNMMI Research|March 27, 2024
Repeatability of <sup>18</sup>F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trialsMark Muzi, Lanell M Peterson, Jennifer M Specht, et al.
Molecular Imaging and Biology|October 17, 2018
Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)Lanell M Peterson, Brenda F Kurland, Erin K Schubert, et al.
EJNMMI Research|June 27, 2012
Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patientsBrenda F Kurland, Vijayakrishna K Gadi, Jennifer M Specht, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2018
Test-Retest Reproducibility of <sup>18</sup>F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local NetworkBrenda F Kurland, Lanell M Peterson, Andrew T Shields, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 30, 2010
Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancerSavannah C Partridge, Risa K Vanantwerp, Robert K Doot, et al.
Pageof 27